Picture of Cosmos Pharmaceutical logo

3349 — Cosmos Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
Consumer DefensivesBalancedMid CapNeutral

Table: Cosmos Pharmaceutical -2025/26 group results

    Jul 13 (Reuters)- 
          Cosmos Pharmaceutical Corp. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              May 31, 2026    May 31, 2025   May 31, 2027     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales         1.10 trln       1.01 trln      1.19 trln      582.70   
               (+8.7 pct)      (+4.8 pct)     (+8.2 pct)    (+8.5 pct) 
  Operating       42.35           40.40          43.00         20.78   
               (+4.8 pct)      (+28.3 pct)    (+1.5 pct)    (+0.5 pct) 
  Recurring       44.61           43.16          45.70         22.18   
               (+3.4 pct)      (+25.8 pct)    (+2.4 pct)    (+1.1 pct) 
  Net
  Net             32.05           30.98          30.70         14.48   
               (+3.4 pct)      (+26.7 pct)    (-4.2 pct)    (-1.2 pct) 
  EPS          404.33 yen      390.86 yen     387.35 yen    182.70 yen 
  Ann Div       82.00 yen       70.00 yen      84.00 yen               
  -Q2 Div       37.50 yen       32.50 yen      42.00 yen               
  -Q4 Div       44.50 yen       37.50 yen      42.00 yen               
  
  NOTE - Cosmos Pharmaceutical Corp..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T
   

Recent news on Cosmos Pharmaceutical

See all news